india: new tb drugs being tested in india

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update INDIA: New TB Drugs Being Tested in India Staff Writer
March 4, 2013

DNA: Daily News & Analysis (India) (03.01.13) Aids Weekly Plus India Health Minister Ghulam Nabi Azad said on March 1 that Indian research institutes are conducting trials to test new TB drugs, including drugs to treat currently drug-resistant TB. Drugs the institutes are testing include Delaminid, Bedaquiline, and PA-824, to treat both drug-sensitive and drug-resistant TB. The All India Institute of Medical Sciences, New Delhi, and the National Institute of Research in TB, Chennai, are taking part in global trials for the new TB drug Bedaquiline (TMC207). Azad noted the Drug Controller General of India (DCGI) had not received an application granting permission for a US drug. Per India’s drug and cosmetic rules, DCGI must grant approval for any new drug to be introduced in the Indian market. Azad declared that, currently, the replacement of drugs used under the Revised National Tuberculosis Control Programme was not required, adding that patients with drug-resistant TB are treated with a regimen containing drugs to which the TB bacillus was not resistant.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response CountyCare Offers Historic Opportunity to Improve Care for People with HIV International AIDS Advocates Demand China Give $1 Billion to Global Fund Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 Screening Events Promote Hepatitis Testing and Prevention during National Hepatitis Awareness Month Zimbabwe activist: Prisoners denied AIDS drugs NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog SWITZERLAND: Swiss TB Rate Below European Average CANADA: New Facility Unveiled for Homeless With Hepatitis C WALES: HIV Patients Are at Risk of Being Identified Because of New Prescribing System, Warns AM MICHIGAN: Michigan Department of Community Health Encourages Testing for America's Silent Epidemic: Viral Hepatitis Study Finds Vitamin C Can Kill Drug-Resistant TB Big jump in HIV among Navajo in New Mexico
Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles. Information in this article was accurate in March 4, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.